Log in

Relevant bibliographies by topics / Renal Transplant

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Renal Transplant'

Author: Grafiati

Published: 4 June 2021

Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Renal Transplant.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Renal Transplant"

1

Rodin, Gary, Karen Voshart, Daniel Cattran, Phillip Halloran, Carl Cardella, and Stanley Fenton. "Cadaveric Renal Transplant Failure: The Short-Term Sequelae." International Journal of Psychiatry in Medicine 15, no. 4 (December 1986): 357–64. http://dx.doi.org/10.2190/j0w3-x04w-7j6c-vq20.

Full text

Abstract:

Quality of life was evaluated in 103 patients initially when each was placed on the waiting list for a cadaveric transplant. Patients who were not transplanted were reassessed six months after being placed on the waiting list. Patients who received a transplant were reassessed six months after the surgery. Cadaveric transplantation was performed in sixty-three patients by the time of follow-up. The mortality rate of 12.7 percent in transplanted patients after six months was more than twice that in patients who remained on the waiting list without a transplant, but this difference was not statistically significant. There was a graft failure rate of 23.6 percent among transplanted patients who survived six months. Graft failures were associated with some deterioration in subsequent physical activity ( F = 5.4, p < 0.03) but not in psychosocial functioning. Successful cadaveric transplants were associated with a marked and significant improvement in psychosocial well-being ( F = 10.5, p < 0.002) after six months even though physical activity did not increase. These findings suggest that 1) a successful cadaveric transplant is associated with an improved quality of life, 2) the graft failure rate of 23 percent with cadaveric transplantation is still appreciable but 3) graft failure is not necessarily associated in the short term with deterioration in psychosocial well-being.

APA, Harvard, Vancouver, ISO, and other styles

2

Dreher, Paulette Cutruzzula, Jessica M. Fazendin, Kelly Lurz, Daniel C. Edwards, Stephen Guy, and Melanie Amster. "Painful angiomyxoid tumor in a failed renal allograft presenting as post-transplant lymphoproliferative disorder." Journal of Nephropathology 9, no. 2 (September 10, 2019): e20-e20. http://dx.doi.org/10.34172/jnp.2020.20.

Full text

Abstract:

Introduction: There exist few reports of de novo tumors involving an allograft kidney, and to the best of our knowledge there are only two previous reports of angiomyxoma Case Presentation: A 53-year-old Caucasian male with end-stage renal disease (ESRD) on hemodialysis (HD) secondary to malakoplakia with three failed prior renal transplants presented for repeat transplant evaluation. Imaging demonstrated a mass of the transplanted kidney suggestive of posttransplant lymphoproliferative disease (PTLPD). A biopsy was obtained revealing a predominance of myxoid material. The patient became increasingly symptomatic from the mass and underwent a palliative right transplant nephrectomy. Final pathology revealed angiomyxoid tumor. Conclusions: Angiomyxomas are asymptomatic, appear as PTLD on imaging and should be considered in the differential diagnosis of masses occurring in renal transplant allografts.

APA, Harvard, Vancouver, ISO, and other styles

3

Self, Michael, Ernest Dunn, John Cox, and Karl Brinker. "Managing Breast Cancer in the Renal Transplant Patient: A Unique Dilemma." American Surgeon 72, no. 2 (February 2006): 150–53. http://dx.doi.org/10.1177/000313480607200211.

Full text

Abstract:

Improvements in immunosuppression have increased patient and graft survival in transplant recipients. As a result, there is greater risk of neoplastic processes such as breast cancer. Treatment in this population is complicated by the necessary immunosuppression, vascular accesses, and transplant grafts. General surgeons may expect to encounter more of these complex patients in the community setting. We sought to evaluate the surgical treatment of breast cancer in patients with renal transplants. Hospital and private physician records were queried to identify patients who developed breast cancer after a renal or pancreatic/renal transplantation. These charts were reviewed for demographics, type of breast cancer and treatment, location of dialysis access, and complications. From June 1, 1994, to May 31, 2004, 14 patients were identified. Eight patients had functioning transplants. All patients underwent operative interventions. Ten patients underwent adjuvant treatment. Three had functioning transplants and chose not to risk the graft with cessation of immunotherapy. However, no patient with functioning transplants who underwent chemotherapy developed organ failure. Breast cancer after transplantation poses a unique dilemma. The threat of transplanted organ failure is a major concern to these patients and often supersedes adjuvant therapies.

APA, Harvard, Vancouver, ISO, and other styles

4

Williams, Shelly, Amy Braden, Brahm Vasudev, Jeanne Palmer, and Eric Cohen. "Renal Transplantation for End-Stage Renal Disease Following Bone Marrow Transplantation: A 10-Year Outcomes Review." Blood 114, no. 22 (November 20, 2009): 4294. http://dx.doi.org/10.1182/blood.v114.22.4294.4294.

Full text

Abstract:

Abstract Abstract 4294 Background The incidence of hematopoietic stem cell transplantations (HSCTs) in the US is increasing dramatically each year. Nephrotoxic agents used in these patients often lead to kidney injury that can be severe and progress to end-stage renal disease (ESRD) requiring long term dialysis or kidney transplant. Kidney transplantation is the best method of renal replacement therapy and maintenance immunosuppression is the mainstay to prevent graft rejection. Immune tolerance is of substantial interest because it obviates the need for long-term immunosuppression. Methods We performed a retrospective analysis of nine patients that developed ESRD after HSCT at the Medical College of Wisconsin. Chart review was performed to obtain demographic information and details of the transplants, patient and transplant outcomes, and various renal and HSCT related parameters. Results A total of nine patients were reviewed. Patient age at the time of HSCT ranged from 25-40 years. ESRD was caused by bone marrow transplant nephropathy (BMT-Np) in seven patients, HUS/TTP in one patient, and anti-TBM nephritis in one patient. Six patients received their kidney from a living related donor (LRD), whereas two patients received living unrelated renal transplants (LURRTx), and one recipient received a deceased donor transplant. Three of the six LRD recipients had same-donor renal and hematopoietic stem cell (HSC) transplants and did not require post-transplant maintenance immunosuppression. Of the two LURRTx recipients, no maintenance immunosuppression was required for the patient receiving same-donor organs. The deceased donor transplant recipient continues to be on immunosuppression. Follow-up ranges from 12-23 years post HSCT and 3-12 years post-renal transplant. Seven of the nine patients have functioning bone marrow and kidney transplants. Their serum creatinine ranges from 0.77 to 1.7 mg/dL. One patient died 24 months post-renal transplant from metastatic vaginal squamous cell cancer and had a functioning bone marrow and kidney at the time of death. Another patient was lost to follow-up and died of unknown cause, although her renal function 34 months post transplant was excellent off maintenance immunosupression. Conclusions Based on our case series, we conclude that the long-term outcome of renal allografts in patients who have received a renal transplant after HSCT is excellent. The overall requirement for immunosuppressive medications in this population is reduced. Disclosures: No relevant conflicts of interest to declare.

APA, Harvard, Vancouver, ISO, and other styles

5

Sidhu, Joginder, Surbhi Bansal, and Hasrat Sidhu. "Incidence and Neurological Complications in Renal Transplant Patients." Asian Pacific Journal of Health Sciences 2, no. 1 (January 2015): 69–72. http://dx.doi.org/10.21276/apjhs.2015.2.1.11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Polytimi, Leonardou, Gioldasi Sofia, and Pappas Paris. "Close to Transplant Renal Artery Stenosis and Percutaneous Transluminal Treatment." Journal of Transplantation 2011 (2011): 1–7. http://dx.doi.org/10.1155/2011/219109.

Full text

Abstract:

Purpose. To evaluate the efficacy of percutaneous transluminal angioplasty (PTA) in the management of arterial stenosis located close to the allograft anastomosis (close-TRAS).Materials and Methods. 31 patients with renal transplants were admitted to our institution because of persistent hypertension and impairment of transplant renal function and underwent angiography for vascular investigation. 27 were diagnosed suffering from transplant renal artery stenosis (TRAS), whereas 4 had severe iliac artery stenosis proximal to the transplant anastomosis (Prox-TRAS). 3 cases of TRAS coexisted with segmental renal arterial stenosis, whereas 3 other cases of TRAS were caused by kinking and focal stenosis in the middle of the transplanted renal artery.Results. Angioplasty and stenting were successfully applied to all patients with iliac artery stenosis as well as to those with TRAS and segmental artery stenosis. Two of three patients with kinking were well treated with angioplasty and stenting, whereas one treated only with angioplasty necessitated surgery. No major procedure-related complications appeared, and the result was decrease of the serum creatinine level and of the blood pressure.Conclusions. PTA is the appropriate initial treatment of TRAS and close-TRAS, with low morbidity and mortality rates, achieving improvement of graft function and amelioration of hypertension.

APA, Harvard, Vancouver, ISO, and other styles

7

McGregor, Tom, Jennifer Bjazevic, Premal Patel, and Joshua Koulack. "Changing of the guard? A glance at the surgical representation in the Canadian renal transplantation community." Canadian Urological Association Journal 10, no. 1-2 (January 14, 2016): 7. http://dx.doi.org/10.5489/cuaj.3256.

Full text

Abstract:

Introduction: Renal transplant is the gold standard treatment for end-stage renal disease (ESRD), and the prevalence of both ESRD and renal transplant has been steadily increasing over the past decade. However, involvement of urology in renal transplant has been declining. We examine the current state of urology involvement in renal transplant programs across Canada.Methods: A telephone survey of all surgical transplant centres in Canada was performed. Information regarding the number of transplant surgeons, their individual training background, and their involvement in specific procedures, including open and laparoscopic living donor nephrectomy, deceased donor nephrectomy, and recipient renal transplant were collected.Results: There are 59 Canadian transplant surgeons, including 27 (46%) who completed a urology residency and 32 (54%) with a general surgery background. With regards to procedures performed, 58 (98%) perform recipient renal transplant surgery, 36 (61%) perform laparoscopic donor nephrectomy, and 17 (29%) perform open donor nephrectomy. There was no significant difference in the number of surgeons that perform renal recipient surgery, laparoscopic or open donor nephrectomies, and deceased donor nephrectomies between surgeons of the two different training backgrounds.Conclusions: The role of urology in Canadian renal transplant has declined significantly over the past decade. Given the medical and surgical complexity of renal transplant, along with the growing need for renal transplants, a multidisciplinary team approach is imperative. Strong urology involvement with the transplant team is crucial for optimal care of these complex patients.

APA, Harvard, Vancouver, ISO, and other styles

8

Subodh, K. Regmi, Jiang Song, and A. Warlick Christopher. "De-Novo Genitourinary Neoplasms in Transplant Recipients: The Present and Future." Cancer Medicine Journal 3, no. 1 (June 30, 2020): 10–22. http://dx.doi.org/10.46619/cmj.2020.3-1016.

Full text

Abstract:

The risk of genitourinary cancers following transplantation is increased following majority of solid organ transplants but is best described following renal transplantation. Increasing average age of the transplant recipient as well as increases in post- transplant survival increases the risk of these malignancies. The risk of Kidney cancer is the highest following most solid organ transplants, whereas prostate cancer risk is lower than the general population in multiple large population-based studies. The etiology of increased risk of cancer following transplant is multifactorial with the predominant influence of immunosuppression and direct toxicity of immunosuppressants, however, the significance of end stage disease particularly in the causation of renal cancer in renal transplant recipients is undeniable. Modifications in immunosuppression regimens as well as changes in the standard treatment principles of some cancers may require changes in the management of some post-transplant malignancies. Standard screening guidelines have not been established but screening for renal tumors in renal transplant recipients is the only widely studied entity. Further work is needed to prepare the urologic oncological community with this once rare population group and standardized recommendations need to be established for screening and for the use of new age cancer therapeutics like immunotherapy.

APA, Harvard, Vancouver, ISO, and other styles

9

Rao, Nitesh N., Chris Wilkinson, Mark Morton, Greg D. Bennett, Graeme R. Russ, Patrick T. Coates, and Shilpa Jesudason. "Successful pregnancy in a recipient of an ABO-incompatible renal allograft." Obstetric Medicine 12, no. 1 (March 7, 2018): 42–44. http://dx.doi.org/10.1177/1753495x17745390.

Full text

Abstract:

Kidney transplantation restores fertility in patients with end-stage renal disease, with many successful pregnancies after kidney transplantation being reported. However, there are little data regarding pregnancy in women transplanted under modern-era desensitisation protocols that utilise rituximab, plasma exchange and intravenous immunoglobulin, including ABO-incompatible transplants. Pregnancies in ABO-incompatible recipients can pose new challenges from an immunological perspective. Here, we report a case of successful pregnancy using in vitro fertilisation, in a renal transplant recipient who underwent desensitisation two years prior, that included use of rituximab and plasma exchange to receive an ABO-incompatible transplant from her husband and subsequent father of the baby. We believe this was the first case of successful pregnancy after ABO-incompatible kidney transplantation in Australia and New Zealand. This case also highlights the difficulties faced in conception following transplantation and demonstrates that in vitro fertilisation utilising ovulation induction can be successfully utilised for conception in this cohort. This recipient also had gestational diabetes, worsening renal function and preterm delivery which are important complications often seen in pregnancies of solid organ transplant recipients.

APA, Harvard, Vancouver, ISO, and other styles

10

Premaratne, Sobath, Jonathan Hopkins, Martin Duddy, Ket Sang Tai, Mark Kay, Radu Rogoveanu, Phil Nicholl, and Alok Tiwari. "Abdominal Aortic Aneurysm Repair in Renal and Liver Transplant Recipients." Vascular and Endovascular Surgery 54, no. 1 (October 10, 2019): 51–57. http://dx.doi.org/10.1177/1538574419880673.

Full text

Abstract:

Background: Abdominal aortic aneurysm (AAA) repair in patients with organ transplant remains a challenge. We looked at AAA repair in patients with organ transplants at our tertiary liver and kidney transplant unit. Methods: A retrospective analysis of a prospectively maintained database was undertaken from January 2008 to July 2018. We looked at patient demographics, type of repair, and technical success including reinterventions, perioperative transplant organ function, and 30-day and 1-year survival rate. Eight of 662 patients who underwent AAA repair had a solid organ transplant. Of these, 5 were kidney transplants, 2 liver transplants, and 1 had kidney and liver transplant; 75% were male; and average age was 63.4 (range: 49-83). All patients had asymptomatic AAAs, and 6 were treated with standard endovascular repair, 1 standard repair with iliac branch device, and 1 open repair. Adjunctive techniques such as CO2 angiograms, deployment of main body through contralateral iliac, low-profile sheaths, custom-made stent grafts, and temporary axillo-femoral shunting were used to protect transplant organs. Thirty-day survival was 100% with 1 death at 5 months from liver failure, and 1 patient has a persistent type-2 endoleak 3 years after the procedure. Conclusion: Abdominal aortic aneurysm repair in patients with organ transplants can be undertaken using adjunctive endovascular and open surgical techniques.

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Renal Transplant"

1

Fratila, Liana M. "Renal transplant outcome assessment /." free to MU campus, to others for purchase, 2004. http://wwwlib.umi.com/cr/mo/fullcit?p1421135.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Wicht, Jonathan H. "Renal Transplant Survey: how standardised is a standard kidney transplant?" Master's thesis, University of Cape Town, 2017. http://hdl.handle.net/11427/24507.

Full text

Abstract:

Aim: The primary intention of the current study was to discover if there are international standards in renal transplantation. Method: A questionnaire was created using an online survey tool (Qualtrics ®), and distributed to a list of email addresses supplied by the unit's senior transplant surgeon. A literature review was performed on the questions and on the history of transplantation. Ethics was approved by FHS HREC number 193/2015. Results: A total of 30 surveys were completed from a total of 147 emails sent (20.4%). Two thirds of respondents work exclusively in the public sector and almost two-thirds (63.3%) of the respondents had been involved in transplantation for over 10 years. Two thirds of the surgeons estimate that their units perform more than 60 transplants per annum. Only 30% (9/30) use living donors in more than 50% of their surgeries. Most (53.3%) perfuse the kidneys both in the donor (in situ) and outside (ex situ or ex vivo). If no anatomic abnormalities were noted in open living donor nephrectomy, 63.3% would prefer to use the left kidney, and the recipient transplantation would be performed on the right side (76.7%). The majority (90%) of surgeons would preserve the vas deferens, but sacrifice the round ligament and inferior epigastric vessels (76.7% and 80% respectively). There is no marked difference for use of either the internal or external iliac artery for the arterial anastomosis, but most use the external iliac vein for venous anastomosis (86.7%). 80% use a ureteroneocystostomy with a tunnel, and 60% use a DJ stent or ureteric catheter and closed suction drain routinely. Two thirds would remove the transurethral catheter on day 4-7 post operatively. 80% routinely biopsy the kidney, and 63.3% would biopsy prior to treating for possible acute renal rejection. Discussion: These results compare with some of the studies found in the literature and operative textbooks. There do appear to be standards noted between most of the respondent's answers. Conclusion: There do appear to be standards for renal transplantation and these are appreciated globally.

APA, Harvard, Vancouver, ISO, and other styles

3

Moreno, Maria Fernanda Costa Henriques. "Adesão terapêutica em doentes submetidos a transplante hepático e renal." Master's thesis, Universidade Nova de Lisboa. Escola Nacional de Saúde Pública, 2012. http://hdl.handle.net/10362/9707.

Full text

Abstract:

RESUMO - Introdução - A não adesão à terapêutica nos doentes transplantados foi identificada em diversos estudos e constitui um fator preditivo de morbilidade e mortalidade. Como em Portugal não existe um conhecimento aprofundado sobre os comportamentos de não adesão nos doentes transplantados, este estudo tem como objetivo a avaliação da adesão terapêutica nos doentes submetidos a transplante hepático e renal e a identificação de fatores associados à não adesão. Metodologia - Foi elaborado e aplicado um questionário a uma amostra de doentes com mais de 18 anos submetidos a transplante renal ou hepático há mais de seis meses. Foi analisada a associação entre o comportamento de não adesão e fatores relacionados com o doente, condição, terapêutica e acesso aos serviços de saúde. Resultados - Dos 75 inquiridos, 60% eram doentes transplantados de fígado e 40% transplantados renais, com uma média de 48 anos e maioritariamente do sexo masculino (65,3%). Entre os inquiridos, verificou-se que 44% admitiu ter tido um comportamento de não adesão aos medicamentos prescritos. Os doentes que reportaram comportamento de não adesão tinham uma média de idades de 44 anos, possuíam como escolaridade o ensino secundário ou curso profissional, trabalhavam ou estudavam, tomavam menos de oito comprimidos por dia e tinham sido transplantados há mais de 5 anos. Adicionalmente, verificou-se que a dieta (28,8%), o exercício físico (33,3%) e o deixar de fumar (10,7%) são as indicações dadas pelos profissionais de saúde que os doentes referiram ter mais dificuldade em cumprir. Conclusão - Com este estudo esperamos ter contribuído para aumentar o conhecimento sobre a adesão à terapêutica nos doentes transplantados, o qual deve ser aprofundado para permitir o desenvolvimento de estratégias efetivas de melhoria da adesão aos planos terapêuticos.
ABSTRACT - Introduction - Treatment non adherence in transplant patients has been identified in numerous studies and is a predictive factor of morbidity and mortality in these patients. As the knowledge about the behaviors of non-adherence in transplant patients in Portugal is not very extensive this study aims to assess the treatment adherence in patients undergone liver and kidney transplantation as well as the identification of factors associated with non adherence. Methodology - A questionnaire was developed and applied to a sample of patients with more than 18 years who undergone kidney or liver transplantation, more than six months ago. It was also analyzed the association between non adherent behavior and patient-related factors, condition, treatment and access to healthcare services. Results - Out of 75 respondents, 60% were liver transplant patients and 40% were kidney transplant recipients, with an average age of 48 years and mostly male (65,3%). Amongst the respondents, 44% admitted having had already a non adherent behaviour to prescribed medications. Patients, who reported non adherent behaviour, had an average age of 44 years, secondary education or professional course, worked or studied, took less than eight pills a day and had been transplanted more than 5 years ago. Additionally it was found that the diet (28.8%), exercise (33.3%) and smoking cessation (10.7%) stand as the indications given by healthcare professionals that patients reported having more difficulty to adhere. Conclusion - With this study we hope to have contributed to increase knowledge about treatment adherence in transplant patients in Portugal, which must be deepened in order to allow the development of effective strategies to improve adherence to treatment plans in these patients.

APA, Harvard, Vancouver, ISO, and other styles

4

Gupta, Ajay. "Viral studies in renal transplant recipients." Thesis, University of Newcastle Upon Tyne, 2009. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.519564.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Hopcraft, LucyAnn. "Neutrophil dysfunction in renal transplant patients." Thesis, University of Liverpool, 2010. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.539559.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Rigatto, Claudio. "Cardiac disease in renal transplant recipients /." St. John's, NF : [s.n.], 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Farmer, Christopher Kenneth Trafford. "Corticosteroid withdrawal in renal transplant recipients." Thesis, King's College London (University of London), 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.415155.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Pereira, Ana Luísa Melo Dias. "Lesões orais em doentes transplantados." Master's thesis, [s.n.], 2015. http://hdl.handle.net/10284/5043.

Full text

Abstract:

Projeto de Pós-Graduação/Dissertação apresentado à Universidade Fernando Pessoa como parte dos requisitos para obtenção do grau de Mestre em Medicina Dentária
Os doentes transplantados são pacientes que cada vez mais nos surgem no consultório dentário e tal deve-se aos grandes avanços que se tem desenvolvido nesta última década quer nas técnicas cirúrgicas, quer nas terapêuticas medicamentosas usadas para evitar uma eventual rejeição do transplante. E é devido ao aumento da sua afluência, mas também por ser um tema pouco referido e no qual ainda é necessário realizar mais estudos, que neste trabalho se pretende retratar quais as lesões orais associadas aos transplantes realizados mais comummente, podendo eles ser do tipo cardíaco, hepático, renal ou de células hematopoiéticas. Tem ainda como objetivo descrever quais as manifestações clínicas das diferentes lesões, quais os sintomas que o paciente apresenta e como as tratar, mas também quais os melhores métodos para ajudar na prevenção destas mesmas. Contudo existe uma carência de protocolos definidos, por isso esta monografia pretende também sugerir alguns, com base em diferentes e variadas propostas feitas por vários autores ao longo desta última década. Este trabalho resume-se à ideia de que é necessário intervir na saúde oral dos pacientes com transplantes, não só para lhes melhorar o dia-a-dia e diminuir as suas comorbilidades, mas também para prevenir e evitar que se iniciem tais transtornos. Transplant patients are patients who increasingly emerge in the dental office and this is due to the great progress that has been developed over the last decade both in surgical techniques and in drug therapies used to prevent a possible rejection of the transplant. It is due to their increased affluence - and with this being a rarely mentioned issue still needing further studies - that this work is intended to portray what oral lesions associated with transplants performed more commonly, them being from the heart, liver, kidney or hematopoietic cells. It is also my goal to describe the clinical manifestations of different lesions and the symptoms of the patient and and how to treat them, but also what are the best methods to help prevent them. However, there is a lack of defined protocols, so this monograph also aims to suggest some, based on different proposals made by several authors over the last decade. This work comes down to the idea that it is necessary to interfere in the oral health of patients with transplants, not only for their everyday lives and decrease their comorbidities, but also to prevent and avoid the start of such disorders.

APA, Harvard, Vancouver, ISO, and other styles

9

Chapman, J. R. "Humoral sensitization of potential renal transplant recipients." Thesis, University of Cambridge, 1987. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.597471.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Sharma, Rajan. "Cardiac risk stratification in renal transplant recipients." Thesis, St George's, University of London, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.423132.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Renal Transplant"

1

Coventry, Brendon J., ed. Cardio-Thoracic, Vascular, Renal and Transplant Surgery. London: Springer London, 2014. http://dx.doi.org/10.1007/978-1-4471-5418-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Calne, S. The ultimate gift: The story of Britain's premier transplant surgeon. London: Headline Book Publishing, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Jong-Tieben, Linda M. de. Human papillomavirus infection and skin cancer in renal transplant recipients. Leiden: University of Leiden, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

United Kingdom Transplant Support Service Authority. Renal transplant audit: United Kingdom and Republic of Ireland : 1981-1991. Bristol: UKTSSA, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

United Kingdom Transplant Support Service Authority. Renal transplant audit 1981-1991: United Kingdom and Republic of Ireland. Bristol: United Kingdom Transplant Support Service Authority, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Caskey, Denise. A health promotion needs assessment of the renal transplant population in Northern Ireland. [s.l: The Author], 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Jurewicz, Wieslaw Adam. Indium-111 labelled autologous platelets in post-transplant monitoring of renal and pancreatic allografts in man. Birmingham: University of Birmingham, 1985.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Spencer, Susan Elva. An investigation of the incidence and potential significance of antibodies to endothelial / monocyte antigensin renal transplant recipients. [s.l: The Author], 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Nessralla, Laurie-Ann. Incidence of rejection, morbidity, mortality and graft function in renal transplant recipients following cyclosporine to azathioprine switch. [New Haven: s.n.], 1990.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

Sherman, Michael Scott. Morbidity, mortality, and graft function in renal transplant recipients: A comparison of the effects of cyclosporine versus azathioprine. [New Haven: s.n.], 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Renal Transplant"

1

Hakenberg, Oliver W. "Renal Transplant." In Blandy's Urology, 127–44. Chichester, UK: John Wiley & Sons, Ltd, 2019. http://dx.doi.org/10.1002/9781118863343.ch8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Brealey, John. "Transplant Renal Biopsies." In Diagnostic Electron Microscopy - A Practical Guide to Interpretation and Technique, 55–88. Chichester, UK: John Wiley & Sons, Ltd, 2013. http://dx.doi.org/10.1002/9781118452813.ch2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Vu, Catherine T., Brandon Doskocil, and Lucas Sheen. "Renal Transplant Interventions." In Transplantation Imaging, 161–82. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-75266-2_9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Mandal, Anil K. "Renal Transplant Rejection." In Assessment of Urinary Sediment by Electron Microscopy, 141–63. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4613-1851-4_6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Russell, Christine, Peter Morris, and Brendon J. Coventry. "Renal Transplant Surgery." In Cardio-Thoracic, Vascular, Renal and Transplant Surgery, 157–62. London: Springer London, 2013. http://dx.doi.org/10.1007/978-1-4471-5418-1_10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Honsová, Eva. "Transplant Histopathology." In Handbook of Renal and Pancreatic Transplantation, 317–34. Chichester, UK: John Wiley & Sons, Ltd, 2012. http://dx.doi.org/10.1002/9781118305294.ch20.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Hilbrands, L. B., A. J. Hoitsma, and R. A. P. Koene. "Costs of drugs used after renal transplantation." In Transplant International, 399–402. Berlin, Heidelberg: Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-662-00818-8_96.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Miller, Joseph B., and K. K. Venkat. "The Renal Transplant Patient." In Challenging and Emerging Conditions in Emergency Medicine, 51–73. Oxford, UK: Wiley-Blackwell, 2011. http://dx.doi.org/10.1002/9781119971603.ch4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Maxwell, Heather, and Nicholas J. A. Webb. "Chronic Renal Transplant Dysfunction." In Pediatric Kidney Disease, 1833–73. Berlin, Heidelberg: Springer Berlin Heidelberg, 2016. http://dx.doi.org/10.1007/978-3-662-52972-0_69.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Chu, Justin, and Lynne Robinson. "The renal transplant patient." In Assisted Reproduction Techniques, 103–9. Chichester, UK: John Wiley & Sons, Ltd, 2021. http://dx.doi.org/10.1002/9781119622215.ch16.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Renal Transplant"

1

S. Pahl, Eric, W. Nick Street, Hans J. Johnson, and Alan I. Reed. "A Predictive Model for Kidney Transplant Graft Survival using Machine Learning." In 4th International Conference on Computer Science and Information Technology (COMIT 2020). AIRCC Publishing Corporation, 2020. http://dx.doi.org/10.5121/csit.2020.101609.

Full text

Abstract:

Kidney transplantation is the best treatment for end-stage renal failure patients. The predominant method used for kidney quality assessment is the Cox regression-based, kidney donor risk index. A machine learning method may provide improved prediction of transplant outcomes and help decision-making. A popular tree-based machine learning method, random forest, was trained and evaluated with the same data originally used to develop the risk index (70,242 observations from 1995-2005). The random forest successfully predicted an additional 2,148 transplants than the risk index with equal type II error rates of 10%. Predicted results were analyzed with follow-up survival outcomes up to 240 months after transplant using Kaplan-Meier analysis and confirmed that the random forest performed significantly better than the risk index (p<0.05). The random forest predicted significantly more successful and longer-surviving transplants than the risk index. Random forests and other machine learning models may improve transplant decisions.

APA, Harvard, Vancouver, ISO, and other styles

2

Li, Xun, Yao Wang, Chengxuan Wang, Sanqing Hu, Ying Xu, Fei Han, and Jianghua Chen. "Prediction of renal transplant rejection and acute tubular necrosis in renal transplant based on SVM." In 2012 5th International Conference on Biomedical Engineering and Informatics (BMEI). IEEE, 2012. http://dx.doi.org/10.1109/bmei.2012.6512936.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

FARIA DOMINGUES, LEONARDO, Marilda Mazzali, and Willian Nishiwaki Alves. "Cutaneous Neoplasms in Renal Transplant Recipients." In XXV Congresso de Iniciação Cientifica da Unicamp. Campinas - SP, Brazil: Galoa, 2017. http://dx.doi.org/10.19146/pibic-2017-78838.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Urban, Matthew W., Carolina Amador, and James F. Greenleaf. "In vivo measurement of renal transplant viscoelasticity." In 2013 IEEE International Ultrasonics Symposium (IUS). IEEE, 2013. http://dx.doi.org/10.1109/ultsym.2013.0136.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Andrews, Peter M., Yu Chen, Jeremiah Wierwille, Daniel Joh, Peter Alexandrov, Derek Rogalsky, Patrick Moody, et al. "Using OCT to predict post-transplant renal function." In SPIE BiOS, edited by Nikiforos Kollias, Bernard Choi, Haishan Zeng, Hyun Wook Kang, Bodo E. Knudsen, Brian J. Wong, Justus F. Ilgner, et al. SPIE, 2013. http://dx.doi.org/10.1117/12.2005962.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Albon, Dana P., Brandon Bowers, Montgomery Roberts, Arjun B. Chatterjee, Rodolfo M. Pascual, Jeffrey Rogers, Edward F. Haponik, and Robert Chin. "Bronchoscopy Yield In Immunocompromised Patients Post Renal Transplant." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a4477.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Akhtar, Sohail, Asma Naseem, Sunil Dodani, Rubina Naqvi, Ejaz Ahmad, Anwar Naqvi, and Adib Rizvi. "Tuberculosis in renal transplant recipients on isoniazid prophylaxis." In ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa2104.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Bronshteyn, I., S. M. Pastores, and N. Halpern. "The Critically Ill Patient with a Renal Transplant." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a1718.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Savas Bozbas, Serife, Suleyman Kanyilmaz, Sule Akcay, Huseyin Bozbas, Cihan Altin, Emir Karacaglar, Haldun Muderrisoglu, and Mehmet Haberal. "Renal Transplant Improves Pulmonary Hypertension In Patients With End Stage Renal Disease." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a5914.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

El-Baz, Ayman, Georgy Gimel'farb, and Mohamed A. El-Ghar. "Image analysis approach for identification of renal transplant rejection." In ICPR 2008 19th International Conference on Pattern Recognition. IEEE, 2008. http://dx.doi.org/10.1109/icpr.2008.4761694.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Renal Transplant"

1

Yang, Luo, Fucong Peng, Changyun Wei, Bei Zhang, Ruiting Wang, and Hongxia Liu. Renal transplant candidates’ or recipients’ perspectives on living donor transplantation: A Systematic Review and Qualitative Meta-synthesis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, September 2021. http://dx.doi.org/10.37766/inplasy2021.9.0101.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Pelletier, Joseph P., Oluwole Fadare, and Yanyun Wu. Post-Renal Transplant Thrombotic Thrombocytopenic Purpura (TTP): Attributable to Immunosuppression or Graft Rejection? Report of Three Cases and Literature Review. Fort Belvoir, VA: Defense Technical Information Center, January 2005. http://dx.doi.org/10.21236/ada429608.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Prostate cancer in renal transplant recipients. BJUI Knowledge, September 2015. http://dx.doi.org/10.18591/bjuik.0379.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Should TURP be performed before or after renal transplant? BJUI Knowledge, September 2016. http://dx.doi.org/10.18591/bjuik.0369.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Review of urological cancer incidence in renal transplant recipients. BJUI Knowledge, September 2017. http://dx.doi.org/10.18591/bjuik.0375.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

What is the Role of renal transplant in HIV positive patients with CKD? BJUI Knowledge, March 2018. http://dx.doi.org/10.18591/bjuik.0372.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!